DK285488A - Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes - Google Patents

Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes

Info

Publication number
DK285488A
DK285488A DK285488A DK285488A DK285488A DK 285488 A DK285488 A DK 285488A DK 285488 A DK285488 A DK 285488A DK 285488 A DK285488 A DK 285488A DK 285488 A DK285488 A DK 285488A
Authority
DK
Denmark
Prior art keywords
peptid
test method
preparation containing
preparation
test
Prior art date
Application number
DK285488A
Other languages
Danish (da)
English (en)
Other versions
DK285488D0 (da
Inventor
Michael Rosenblatt
Lynn H Caporale
Ruth F Nutt
Jay J Levy
Michael Chorev
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK285488D0 publication Critical patent/DK285488D0/da
Publication of DK285488A publication Critical patent/DK285488A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK285488A 1987-05-26 1988-05-25 Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes DK285488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/054,359 US4771124A (en) 1987-05-26 1987-05-26 Parathyroid hormone antagonists with simplified synthetic methodology

Publications (2)

Publication Number Publication Date
DK285488D0 DK285488D0 (da) 1988-05-25
DK285488A true DK285488A (da) 1989-02-13

Family

ID=21990501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK285488A DK285488A (da) 1987-05-26 1988-05-25 Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes

Country Status (4)

Country Link
US (1) US4771124A (de)
EP (1) EP0293159A3 (de)
JP (1) JPS63316800A (de)
DK (1) DK285488A (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725319A1 (de) * 1987-07-30 1989-02-09 Biotechnolog Forschung Gmbh Pth-modifikationen und therapeutische zusammensetzungen, die sie enthalten und daraus bestehen
AU2788089A (en) * 1987-10-20 1989-05-23 Michael F. Holick Regulation of cell proliferation and differentiation using peptides
US5527772A (en) * 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US5114843A (en) * 1988-05-09 1992-05-19 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5744444A (en) * 1989-10-27 1998-04-28 Haemopep Pharma Gmbh HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
US5087561A (en) * 1990-06-28 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists modified at position 13 by biotin
CA2087190A1 (en) * 1990-07-13 1992-01-14 Fred E. Cohen Parathyroid hormone analogues modified at positions
US5149779A (en) * 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5849695A (en) * 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
US5955425A (en) 1996-08-02 1999-09-21 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5660826A (en) * 1995-06-06 1997-08-26 The Regents Of The University Of California Therapeutic sepsis treatment using antagonists to PTHrP
SK40599A3 (en) * 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
SK151599A3 (en) 1997-05-14 2000-09-12 Rhone Poulenc Rorer Pharma Peptide parathyroid hormone analogs
WO1998051329A1 (en) * 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Cachexia remedy
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
JP4516711B2 (ja) * 1999-12-28 2010-08-04 中外製薬株式会社 安定な抗体組成物及び注射製剤
US8029793B2 (en) * 2000-04-28 2011-10-04 Chugai Seiyaku Kabushiki Kaisha Methods for inhibiting cell proliferation
EP1312376A1 (de) * 2000-08-11 2003-05-21 Chugai Seiyaku Kabushiki Kaisha Substanzen zur gefässrelaxation
EP1312378A4 (de) * 2000-08-16 2004-03-17 Chugai Pharmaceutical Co Ltd Substanzen zur verbesserung der symptome bei gelenkserkrankungen
CA2454275C (en) * 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
AU2003207512B2 (en) * 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
CA2496618A1 (en) * 2002-05-23 2003-12-04 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US20050215476A1 (en) * 2004-01-21 2005-09-29 Unigene Laboratories Inc. Amidated parathyroid hormone fragments and uses thereof
EP2054077A4 (de) * 2006-08-04 2010-10-13 Gen Hospital Corp Polypeptidderivate des parathyroidhormons (pth)
AU2007313001B2 (en) * 2006-10-13 2012-03-22 Eli Lilly And Company Pegylated PTH as PTH receptor modulators and uses thereof
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone

Also Published As

Publication number Publication date
JPS63316800A (ja) 1988-12-26
DK285488D0 (da) 1988-05-25
US4771124A (en) 1988-09-13
EP0293159A3 (de) 1990-05-09
EP0293159A2 (de) 1988-11-30

Similar Documents

Publication Publication Date Title
DK285488D0 (da) Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK66988D0 (da) Cholestyraminpraeparat og fremgangsmaade til fremstilling deraf
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
NO871365L (no) Fremgangsmaate og anordning for fremstilling av nitrogen.
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK355387D0 (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
NO870210D0 (no) Fremgangsmaate og anordning for avskinning.
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK397788A (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK0425001T3 (da) Naturlige delta-lactoner og fremgangsmåde til fremstilling deraf
DK293786A (da) Steroido(3,2-c)pyrazol og fremgangsmaade til fremstilling deraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK641989A (da) Bis-arylphosphatestere, deres fremstilling og anvendelse
DK487688D0 (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK624588A (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
NO894767L (no) Fremgangsmaate og innretning for proevetaging.
DK129689D0 (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
NO873029D0 (no) Metylenpreparat og anvendelse derav.
NO884325D0 (no) Fremgangsmaate og anordning for olefinseparasjon.
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK65188D0 (da) Cyclisk peptid og fremgangsmaade til fremstilling deraf
DK335288D0 (da) Peptolidderivater og fremgangsmaade til fremstilling deraf
IS3269A7 (is) Ný peptíð og notkun þeirra

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment